Advertisement
Screener

NeuroOne Medical Technologies Corporation (NMTC) Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount

NeuroOne Medical Technologies Corporation Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount

NeuroOne Medical Technologies Corporation (NMTC) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $11.92 million for the 12-month period ending 2022-09-30, per its 10-K filed 2022-12-22.

Discontinued › Notes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets

us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2022-12-22

  • NeuroOne Medical Technologies Corporation valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $11.92M, a 35.31% increase from fiscal 2021.
  • NeuroOne Medical Technologies Corporation valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2021 was $8.81M, a 54.66% increase from fiscal 2020.
  • NeuroOne Medical Technologies Corporation valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2020 was $5.70M, a 44.14% increase from fiscal 2019.
  • NeuroOne Medical Technologies Corporation valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2019 was $3.95M.
Period endValuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month
2022-09-30$11.92M
10-K · filed 2022-12-22
2021-09-30$8.81M
10-K · filed 2022-12-22
2020-09-30$5.70M
10-K/A · filed 2022-05-31
2019-09-30$3.95M
10-K · filed 2020-12-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
Sintx Technologies, Inc. (SINT)United States$0.012B-1.10
Picard Medical, Inc. (PMI)United States$0.011B-0.01
ALLURION TECHNOLOGIES, INC. (ALUR)United States$0.010B
CERENOME, INC. (CNSY)United States$0.014B
SeaStar Medical Holding Corp (ICU)United States$0.015B-1.14
Co-Diagnostics, Inc. (CODX)United States$0.007B-0.32
Modular Medical, Inc. (MODD)United States$0.018B-0.88
enVVeno Medical Corp (NVNO)United States$0.006B-0.48
Sonoma Pharmaceuticals, Inc. (SNOA)United States$0.006B-2.59
INTELLIGENT BIO SOLUTIONS INC. (INBS)United States$0.005B